Singapore - English - HSA (Health Sciences Authority)

beng kang import & export - general hospital - the acupuncture needles is a device to pierce the skin in the practice of acupuncture by qualified tcm practitioners.

United States - English - NLM (National Library of Medicine)

medi-physics inc. - iobenguane i-123 (unii: p2th1xyz84) (iobenguane i-123 - unii:p2th1xyz84) - iobenguane i-123 2 mci in 1 ml - adreview is a radiopharmaceutical indicated for use in the detection of primary or metastatic pheochromocytoma or neuroblastoma as an adjunct to other diagnostic tests. adreview is indicated for scintigraphic assessment of sympathetic innervation of the myocardium by measurement of the heart to mediastinum (h/m) ratio of radioactivity uptake in patients with new york heart association (nyha) class ii or class iii heart failure and left ventricular ejection fraction (lvef) ≤ 35%. among these patients, adreview may be used to help identify patients with lower one and two year mortality risks, as indicated by an h/m ratio ≥ 1.6. limitations of use: in patients with congestive heart failure, adreview utility has not been established for: - selecting a therapeutic intervention or for monitoring the response to therapy; - using the h/m ratio to identify a patient with a high risk for death. adreview is contraindicated in patients with known hypersensitivity to iobenguane or iobenguane sulfate. risk summary radioactive iodine products cross the placenta and can permanently impair fetal thyroid function. administration of an appropriate thyroid blocking agent is recommended before use of adreview in a pregnant woman to protect the woman and fetus from accumulation of i 123 [see dosage and administration (2.2) ]. there are no available data on adreview use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with iobenguane i 123. all radiopharmaceuticals have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose. advise pregnant women of the potential risks of fetal exposure to radiation doses with administration of adreview. adreview contains 10.3 mg/ml of benzyl alcohol. because benzyl alcohol is rapidly metabolized by a pregnant woman, benzyl alcohol exposure in the fetus is unlikely. however, adverse reactions have occurred in premature neonates and low birth weight infants who received intravenously administered benzyl alcohol-containing drugs [see warnings and precautions (5.3) and use in specific populations (8.4)]. the estimated background risk of major birth defects and miscarriage for the indicated population(s) is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. risk summary iodine 123 (i 123), the radionuclide in adreview, is present in human milk. there is no information on the effects on the breastfed infant or on milk production. advise a lactating woman to interrupt breastfeeding and pump and discard breastmilk for at least 6 days (>10 physical half-lives) after adreview administration in order to minimize radiation exposure to a breastfed infant. the safety and effectiveness of adreview have been established in the age groups 1 month to 16 years in patients with known or suspected neuroblastoma [see clinical studies (14.1)] . safety and effectiveness in pediatric patients below the age of 1 month or in any pediatric patient with congestive heart failure have not been established. serious adverse reactions including fatal reactions and the "gasping syndrome" occurred in premature neonates and infants in the neonatal intensive care unit who received drugs containing benzyl alcohol as a preservative. in these cases, benzyl alcohol dosages of 99 to 234 mg/kg/day produced high levels of benzyl alcohol and its metabolites in the blood and urine (blood levels of benzyl alcohol were 0.61 to 1.378 mmol/l). additional adverse reactions included gradual neurological deterioration, seizures, intracranial hemorrhage, hematologic abnormalities, skin breakdown, hepatic and renal failure, hypotension, bradycardia, and cardiovascular collapse. preterm, low-birth weight infants may be more likely to develop these reactions because they may be less able to metabolize benzyl alcohol. when administering adreview in infants consider the combined daily metabolic load of benzyl alcohol from all sources including adreview (contains 10.3 mg of benzyl alcohol per ml) and other drugs containing benzyl alcohol. the minimum amount of benzyl alcohol at which serious adverse reactions may occur is not known [see warnings and precautions (5.3)] . in clinical studies of adreview in heart disease, 27% of subjects were 65-74 years of age and 17% of subjects were 75 years of age or over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. adreview is excreted by the kidneys, and the risks of adverse reactions, increased radiation dose, and occurrence of falsely negative imaging results, may be greater in patients with severely impaired renal function. because elderly patients are more likely to have decreased renal function, care should be taken in dose selection and image interpretation. consider assessment of renal function in elderly patients prior to adreview administration.

Australia - English - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - iobenguane (123i) sulfate, quantity: 100 mbq/ml - injection, solution - excipient ingredients: monobasic sodium phosphate dihydrate; dibasic sodium phosphate; ascorbic acid; benzyl alcohol; water for injections - diagnostic scintigraphic localisation of phaeochromocytomas, paragangliomas (chemodectomas), ganglioneuroblastomas and ganglioneuromas. detection, staging and follow-up on therapy of neuroblastomas.

Singapore - English - HSA (Health Sciences Authority)

beng kang import & export - general hospital - disposable sterile acupuncture needle is a professional appliance for acupuncture treatment.

Singapore - English - HSA (Health Sciences Authority)

beng kang import & export - general hospital - multi-purpose health device is an electro-acupuncture device. it is intended to be used in the practice of acupuncture by licensed practitioners of acupuncture

Singapore - English - HSA (Health Sciences Authority)

beng kang import & export - physical medicine - xinfeng infrared therapeutic lamps that emits the infrared spectrum to provide topical heating for the purpose of elevating tissue temperature, to temporarily increase local blood circulation, and to temporarily relieve minor muscle and joint pain and stiffness. the lamps may also help to relieve minor pain associated with muscle spasms, minor sprains and strains, and minor muscular back pain.

Singapore - English - HSA (Health Sciences Authority)

beng kang import & export - granules (internal use)

Singapore - English - HSA (Health Sciences Authority)

beng kang import & export - granules (internal use)

Singapore - English - HSA (Health Sciences Authority)

beng kang import & export - granules (internal use)

Singapore - English - HSA (Health Sciences Authority)

beng kang import & export - granules (internal use)